Analysis reveals scar-like transcriptomic profile linked to favorable prognosis after neoadjuvant therapy in muscle-invasive bladder cancer patients.
Figure S8. Comparing quantitative immunohistochemistry (IHC) scores between scar-like cases identified by the transcriptomic classifier (TC) and remaining samples from the ABACUS cohort.
No takes yet. Share an insight, caveat, or question.
Jong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: